UK markets closed

Adaptimmune Therapeutics plc (ADAP)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.0750+0.0150 (+1.42%)
At close: 04:00PM EDT
1.0900 +0.01 (+1.40%)
After hours: 07:36PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
143,991
108,033
149,948
56,882
Other short-term investments
2,947
96,572
219,632
311,335
Total cash
146,938
204,605
369,580
368,217
Net receivables
821
7,435
752
139
Inventory
-
-
-
2,086
Other current assets
3,741
3,206
2,828
2,530
Total current assets
207,552
255,370
415,458
398,152
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
130,948
119,593
94,875
77,755
Accumulated depreciation
-59,240
-48,058
-43,506
-31,097
Net property, plant and equipment
71,708
71,535
51,369
46,658
Intangible assets
330
442
1,000
1,730
Other long-term assets
3,026
1,569
1,718
4,602
Total non-current assets
75,064
73,546
54,087
52,990
Total assets
282,616
328,916
469,545
451,142
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
8,128
4,753
8,113
6,389
Accrued liabilities
28,854
29,060
29,582
27,032
Deferred revenues
28,973
23,520
22,199
2,832
Other current liabilities
51
2,155
327
47
Total current liabilities
72,788
64,501
62,541
39,073
Non-current liabilities
Deferred revenues
149,060
160,892
177,223
49,260
Other long-term liabilities
1,404
1,296
673
644
Total non-current liabilities
170,315
182,537
201,044
70,842
Total liabilities
243,103
247,038
263,585
109,915
Stockholders' equity
Common stock
1,865
1,399
1,337
1,325
Retained earnings
-1,023,173
-909,302
-743,846
-585,756
Accumulated other comprehensive income
-3,748
-875
-11,142
-10,048
Total stockholders' equity
39,513
81,878
205,960
341,227
Total liabilities and stockholders' equity
282,616
328,916
469,545
451,142